Showing results (1591-1600 of 3,569) with videos related to
Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|February 12, 2014
Transitioning to and from the novel oral anticoagulants: a management strategy for cliniciansElsayed Abo-Salem, Richard BeckerJournal of Thrombosis and Thrombolysis|March 5, 2014
Advances in interventional cardiology: MitraClipSaid Alsidawi, Mohamed Effat, Tarek HelmyJournal of Thrombosis and Thrombolysis|March 4, 2008
The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpuraSemir Pasa, Abdullah Altintas, Timucin Cil, et al.Journal of Thrombosis and Thrombolysis|March 11, 2008
A descriptive evaluation of unfractionated heparin use during pregnancyNathan P Clark, Thomas Delate, Daniel M Witt, et al.Journal of Thrombosis and Thrombolysis|March 12, 2008
Association of angiographic perfusion score following percutaneous coronary intervention for ST-elevation myocardial infarction with left ventricular remodeling at 6 weeks in GRACIA-2JoEllyn M Abraham, C Michael Gibson, Gonzalo Pena, et al.Journal of Thrombosis and Thrombolysis|October 25, 2018
Acute cytomegalovirus infection associated with pulmonary embolism treated successfully with rivaroxaban: case reportClarissa Maria Gomes de Almeida, Fauze Camargo Maluf, Feres Camargo Maluf, et al.Journal of Thrombosis and Thrombolysis|November 19, 2018
Comorbid cancer and use of thrombolysis in acute pulmonary embolismErin R Weeda, Kevin M Hakamiun, Hannah X Leschorn, et al.Journal of Thrombosis and Thrombolysis|February 24, 2017
Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a reviewHomam Ibrahim, Sunil V RaoJournal of Thrombosis and Thrombolysis|March 13, 2019
Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT StudySeth Woodruff, Agnes Y Y Lee, Marc Carrier, et al.Journal of Thrombosis and Thrombolysis|February 22, 2019
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE TrialJeffrey B Washam, Stefan H Hohnloser, Renato D Lopes, et al.Pageof 357